Tissue Engineering And Nanotheranostics

“9.61x6.69” b2815 Tissue Engineering and Nanotheranostics

Multifunctional Nanomaterials for Cancer Theranostics 259

imaging, theranostics, and targeted tracking. Biomaterials 46 , 149–

158 (2015).

63. Yang K, Feng L, Shi X, Liu Z. Nano­graphene in biomedicine:
    Theranostic applications. Chem. Soc. Rev. 42 , 530–547 (2013).


64. Chen D, Dougherty CA, Zhu K, Hong H. Theranostic applications of
    carbon nanomaterials in cancer: Focus on imaging and cargo delivery.
    J. Control. Release 210 , 230–245 (2015).


65. Bartelmess J, Quinn SJ, Giordani S. Carbon nanomaterials: Multi­
    functional agents for biomedical fluorescence and Raman imaging.
    Chem. Soc. Rev. 44 , 4672–4698 (2015).


66. Song J, Wang F, Yang X, Ning B, Harp MG, Culp SH, Hu S, Huang
    P, Nie L, Chen J, Chen X. Gold Nanoparticle coated carbon nanotube
    ring with enhanced raman scattering and photothermal conversion
    property for theranostic applications. J. Am. Chem. Soc. 138 , 7005–
    7015 (2016).


67. Kim JY, Ryu JH, Schellingerhout D, Sun IC, Lee SK, Jeon S, Kim J,
    Kwon IC, Nahrendorf M, Ahn CH, Kim K, Kim DE. Direct imaging
    of cerebral thromboemboli using computed tomography and fibrin­
    targeted gold nanoparticles. Theranostics 5 , 1098–1114 (2015).


68. Chen M, Tang S, Guo Z, Wang X, Mo S, Huang X, Liu G, Zheng N.
    Core­shell Pd@Au nanoplates as theranostic agents for in vivo photoa­
    coustic imaging, CT imaging, and photothermal therapy. Adv. Mater.
    26 , 8210–8216 (2014).


69. Bollhorst T, Shahabi S, Worz K, Petters C, Dringen R, Maas M,
    Rezwan K. Bifunctional submicron colloidosomes coassembled from
    fluorescent and superparamagnetic nanoparticles. Angewandte Chemie
    54 , 118–123 (2015).


70. Yang K, Hu L, Ma X, Ye S, Cheng L, Shi X, Li C, Li Y, Liu Z.
    Multimodal imaging guided photothermal therapy using functional­
    ized graphene nanosheets anchored with magnetic nanoparticles. Adv.
    Mater. 24 , 1868–1872 (2012).


71. Gelderblom H, Verweij J, Nooter K, Sparreboom A. Cremophor EL:
    the drawbacks and advantages of vehicle selection for drug formula­
    tion. Eur. J. Cancer 37 , 1590–1598 (2001).


72. Cho K, Wang X, Nie S, Chen ZG, Shin DM. Therapeutic nanoparti­
    cles for drug delivery in cancer. Clin. Cancer Res. 14 , 1310–1316
    (2008).


73. Cole JT, Holland NB. Multifunctional nanoparticles for use in thera­
    nostic applications. Drug Deliv. Transl. Res. 5 , 295–309 (2015).